# Individualized Precise Radiotherapy With the Guidance of Radiosensitivity of Locally Advanced Cervical Cancer

> **NCT03163979** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Nanjing Medical University** · enrollment: 300 (estimated)

## Conditions studied

- Cervical Cancer

## Interventions

- **BIOLOGICAL:** 18F-FDG PET/CT and Comet assay guide RapidArc
- **BIOLOGICAL:** 18F-FDG PET/CT and Comet assay guide IMRT
- **BIOLOGICAL:** RapidArc
- **BIOLOGICAL:** 7f-IMRT

## Key facts

- **NCT ID:** NCT03163979
- **Lead sponsor:** Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-07-01
- **Primary completion:** 2019-04-30
- **Final completion:** 2019-07-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2017-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03163979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03163979, "Individualized Precise Radiotherapy With the Guidance of Radiosensitivity of Locally Advanced Cervical Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03163979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*